Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Shalin J. Shah Image

      Shalin J. Shah

      Department of Radiation Oncology, Division of Radiation Oncology

      Present Title & Affiliation

      Primary Appointment

      Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Clinical Section Chief - Houston Area Locations, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Sugar Land, TX

      Research Interests

      Dr. Shah is actively working to improve access to clinical trials for patients in the community.   He is doing this from the ground up, working with both researchers and administrators to improve the clinical trial infrastructure available at the Houston Area Locations.

      ACTIVE TRIALS

      Research Trial – A Randomized Comparision of a Plant Based Tube Feed (Liquid Hope) versus Standard of Care Tube Feeds for Head and Neck Cancer Patients. 2019-present

      Clinical Interests

       As a radiation oncologist charged with the mission of helping patients fight cancer, I specialize in treating all types of cancers, with a focus on Head and Neck as well as Prostate Cancers. I am actively involved in expanding the access to Proton Therapy for patients in the Houston Area Locations.

      Education & Training

      Degree-Granting Education

      2002Albert Einstein College of Medicine, Bronx, New York, US, MD
      1997Cornell University, College of Agriculture and Life Sciences, Ithaca, New York, US, BS in Biometry and Statistics-with Distinction

      Postgraduate Training

      2012-2012Ayurveda Training Course for Health Professionals-Level I, Maharishi Ayurveda Association of America, La Jolla, California
      2009-2011Lifestyle Counselor, Ayurvedic Medicine, American Institute of Vedic Studies, Santa Fe, New Mexico
      2007-2008Clinical Research Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2002-2007Clinical Residency, Albert Einstein College of Medicine/Montefiore Hospital, Bronx, New York
      2002-2003Clinical Rotations, Albert Einstein College of Medicine/Montefiore Hospital, Bronx, New York
      2001-2002Research Fellowship, Albert Einstein College of Medicine, Bronx, New York

      Licenses & Certifications

      2020Florida Medical License
      2020Arizona Medical License
      2020Georgia Medical License
      2020Tennessee Medical License
      2020Mississippi Medical License
      2020Oklahoma Medical License
      2020Louisiana Medical License
      2020Washington Medical License
      2020Alabama Medical License
      2017American Board of Medical Quality
      2011DEA
      2010DPS
      2008American Board of Radiology
      2007Texas Medical License

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2014

      Assistant Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014

      Administrative Appointments/Responsibilities

      Division Wellness Lead, Radiation Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present

      Clinical Section Chief - Houston Area Locations, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Sugar Land, TX, 2019 - Present

      Center Medical Director, MD Anderson Cancer Center - Sugar Land Regional Care Center, Sugar Land, TX, 2011 - 2014

      Other Professional Positions

      Advisory Board, Blue Cure Foundation, Houston, TX, 2013 - Present

      Executive Board, Indo American Cancer Awareness Network, Houston, TX, 2012 - Present

      Executive Board Member, Fort Bend Medical Society, Sugar Land, TX, 2012 - 2014

      Research Fellowship, Albert Einstein Summer Research Fellowship, Department of Infectious Diseases, Beth Israel Hospital, New York, NY, 1998 - 1998

      International Clinical Oncology Fellowship, M.P. Shah Cancer Hospital, Amdavad, 1995 - 1995

      Intramural Institutional Committee Activities

      Physician Reviewer, Clinical Faculty Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2025

      Extramural Institutional Committee Activities

      Member, Radiation Oncology Clinical Research Council, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Member, HAL Executive Research Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Committee Member, Electronic Medical Record (Epic) Working Group, The University of Texas MD Anderson Cancer Center, 2015 - Present

      Leader, Patient Delays Project Workgroup, The University of Texas MD Anderson Cancer Center, 2014 - 2014

      Board Member, Physicians Relations Advisory Board, The University of Texas MD Anderson Cancer Center, 2011 - Present

      Editorial Activities

      Co-Founder - Inaugural Deputy Editor in Chief, Advances in Cancer Education - Quality Improvement, 2024 - Present

      Contributing Editor, PLOS One, 2019 - Present

      Honors & Awards

      2025 - PresentInstitutional Research Award for Community Outreach, The University Of Texas MD Anderson Cancer Center
      2019Luis Delclos Excellence in Teaching Award - 2019, MD Anderson Cancer Center
      2009 - 2023America's Top Oncologists, Consumer Research Council of America
      2008 - 2013Patient's Choice Award, Vitals.com
      2006 - 2007Chief Resident, The University of Texas M.D. Anderson Cancer Center - Department of Radiation Oncology
      2005 - 2006ASCO International Mentorship Award, ASCO
      2003Community Service Award, BJ Medical Alumni Association
      2002Distinction for Research in Radiation Oncology, Albert Einstein College of Medicine
      2001 - 2002Albert Einstein Research Fellowship, Albert Einstein College of Medicine
      1998Albert Einstein Summer Research Award, Albert Einstein College of Medicine
      1997Golden Key National Honor Society, Golden Key National Honor Society
      1997Graduation with Distinction, Cornell University
      1997Dean's Award for Academic Excellence, College of Agriculture and Life Sciences
      1994International Clinical Oncology Fellowship, Gujarat Cancer Society
      1993 - 1997Dean's list for the College of Agriculture and Life Sciences, Cornell University
      1993Faculty Award for Excellence in Biology, Irvington High School
      1993Texaco Star Academic Challenge Scholarship, Texaco Corporation
      1992Dartmouth Book Award, Dartmouth Alumni Association

      Professional Memberships

      Indo American Cancer Network

      2012 - Present

      Fort Bend Medical Society

      2012 - 2014

      Gilbert H. Fletcher Society

      2011 - Present

      Society for Integrative Oncology

      2010 - Present

      American Society of Clinical Oncology

      2002 - Present

      American Society for Radiation Oncology

      2002 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Head and Neck Radiation Oncology - Contouring, Planning, Delivery. Invited. Head and Neck Surgery Rounds, US.
      2. 2025. Treatment and Supportive Care for Patients with Head & Neck Cancer: A Multidisciplinary Approach. Invited. Advanced Practice Provider Oncology Summit. Austin, Texas, US.

      Regional Presentations

      1. 2025. Head and Neck Tumor Board. Invited. Austin APP Oncology Summit. Georgetown, TX, US.
      2. 2024. Radiation Therapy for Dupuytrens Disease. Invited. Grand Rounds. Houston, TX, US.
      3. 2012. Radiation Therapy for Prostate Cancer. Conference. Radiation Therapy for Prostate Cancer, US.

      National Presentations

      1. 2025. Benign Diseases Panel. Panelist. ASTRO'S 67th Annual Meeting. San Francisco, CA, US.
      2. 2014. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irraditation: Results of a randomized trial. Conference. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irraditation: Results of a randomized trial. San Francisco, CA, US.
      3. 2014. The Rising Tide of Cancer in South Asians - How We Can Best Protect Ourselves. Conference. The Rising Tide of Cancer in South Asians - How We Can Best Protect Ourselves, US.
      4. 2013. How is Cancer Diagnosed and Treated: The Process Explained. Conference. How is Cancer Diagnosed and Treated: The Process Explained. Houston, TX, US.
      5. 2012. Identification of Symptom Clusters in Patients on a 'Road To Wellness Program' Undergoing Radiation Therapy for Breast Cancer. Conference. Identification of Symptom Clusters in Patients on a 'Road To Wellness Program' Undergoing Radiation Therapy for Breast Cancer. Albuquerque, NM, US.
      6. 2011. Mind and Body - A Holistic Approach. Conference. Mind and Body - A Holistic Approach. Houston, TX, US.
      7. 2011. Analysis of Intra-Fraction Chest Wall Motion During Breath Hold Treatment for Left Sided Breast Cancer. Conference. Analysis of Intra-Fraction Chest Wall Motion During Breath Hold Treatment for Left Sided Breast Cancer. Vancouver.
      8. 2009. Inter-fractional Movement of the Larynx and Oropharynx during Radiotherapy. Conference. Inter-fractional Movement of the Larynx and Oropharynx during Radiotherapy. Houston, TX, US.
      9. 2007. Feasibility of CT/MRI Compatible Cervix Sleeve for High Dose Rate Image-Guided Brachytherapy in Cervix Cancer. Conference. Feasibility of CT/MRI Compatible Cervix Sleeve for High Dose Rate Image-Guided Brachytherapy in Cervix Cancer. San Diego, CA, US.
      10. 2007. Whole Pelvis Radiation Therapy Followed by a PD-103 Brachytherapy Boost in Patients with Intermediate or High Risk Prostate Cancer. Conference. Whole Pelvis Radiation Therapy Followed by a PD-103 Brachytherapy Boost in Patients with Intermediate or High Risk Prostate Cancer. Chicago, IL, US.
      11. 2007. Imaging in the Treatment of Breast Cancer. Conference. 1199 Educational Symposium. New York, NY, US.
      12. 2006. IOral Presentation, ICRU Reference Points Underestimate Rectal and Bladder Doses as Compared to CT Planned Dose-Volume Histograms in Interstitial HDR Brachytherapy of Locally Advanced Cervix Carcinoma. Conference. IOral Presentation, ICRU Reference Points Underestimate Rectal and Bladder Doses as Compared to CT Planned Dose-Volume Histograms in Interstitial HDR Brachytherapy of Locally Advanced Cervix Carcinoma. Philadelphia, PA, US.
      13. 2006. Image-Guided Tandem and Colpostate High Dose Rate Brachytherapy for Cervical Cancer. Conference. Image-Guided Tandem and Colpostate High Dose Rate Brachytherapy for Cervical Cancer. Philadelphia, PA, US.
      14. 2006. ICRU Points Significantly Underestmates the Bladder and Rectal Dose Delivereed by HDR Brachytherapy for Cervical Cancer. Conference. ICRU Points Significantly Underestmates the Bladder and Rectal Dose Delivereed by HDR Brachytherapy for Cervical Cancer. Philadelphia, PA, US.
      15. 2005. Oral Presentation,Cytotoxicity and Radiosensitization in Cervical Carcinoma Cells by ON 01910, A Novel Polo-Like Kinase 1 Inhibitor. Conference. Oral Presentation,Cytotoxicity and Radiosensitization in Cervical Carcinoma Cells by ON 01910, A Novel Polo-Like Kinase 1 Inhibitor. Denver, CO, US.
      16. 2005. Targeting the Tie-2 Receptor Tyrosine Kinase Pathway for Radiosensitization of Prostate Cancer. Conference. Targeting the Tie-2 Receptor Tyrosine Kinase Pathway for Radiosensitization of Prostate Cancer. Denver, CO, US.
      17. 2005. ON01910, A Novel benzyl styrl sulfone is a promising radiosensitizer with a good therapeutic ratio. Conference. ON01910, A Novel benzyl styrl sulfone is a promising radiosensitizer with a good therapeutic ratio. San Francisco, CA, US.
      18. 2005. Interstitial Brachytherapy for the Perioperative Treatment of Soft Tissue Sarcoma with Positive or Close Margins. Conference. Interstitial Brachytherapy for the Perioperative Treatment of Soft Tissue Sarcoma with Positive or Close Margins. San Francisco, CA, US.
      19. 2002. Radiation Induced Liver Damage (RILD) in a Cirrhotic Rat Model. Conference. Radiation Induced Liver Damage (RILD) in a Cirrhotic Rat Model. New Orleans, LA, US.
      20. 2001. Oral Presentation, A Novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. Conference. Oral Presentation, A Novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. San Francisco, CA, US.
      21. 2001. Flt-3-Ligand in Combination with CD40 Ligand Gene Transfer Improves Survival in Mice with Diffuse Hepatocellular Carcinoma. Conference. Flt-3-Ligand in Combination with CD40 Ligand Gene Transfer Improves Survival in Mice with Diffuse Hepatocellular Carcinoma. Dallas, TX, US.
      22. 2001. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. Conference. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulation by Flt3-Ligand (Flt3L) following whole liver irradiation and radioinducible HSV-TK Gene Therapy. San Francisco, CA, US.
      23. 2001. Selective Hepatic Lobar Repopulation by Transplanted Hepatocytes After Ligation of a Portal Vein Branch and Preparative Irradiation. Conference. Selective Hepatic Lobar Repopulation by Transplanted Hepatocytes After Ligation of a Portal Vein Branch and Preparative Irradiation. Dallas, TX, US.

      International Presentations

      1. 2025. Multidisciplinary Management of Dupuytrens Disease. Invited. 80TH Annual Meeting Of The American Society For Surgery Of The Hand. Vancouver, CA.
      2. 2023. Adaptive Therapy in Head and Neck Cancer. Invited. SBRT - Brazil Radiation Therapy Society. rio de janeiro, BR.
      3. 2019. Proton Therapy in Head and Neck Malignancies. Invited. Indian Radiation Oncology Association National Conference. Ahmedabad, IN.
      4. 2012. HPV Positive Malignancies in Head and Neck Carcinoma. Invited. Indian Radiation Oncology Association (AROICON). Patna, IN.
      5. 2007. Technique for Customized Parametrial Boost Fields for Locally Advanced Cervical Carcinoma using Nucletron Plato & Varian Varis Planning Systems. Conference. Technique for Customized Parametrial Boost Fields for Locally Advanced Cervical Carcinoma using Nucletron Plato & Varian Varis Planning Systems. Rome, IT.

      Formal Peers

      1. 2010. Multidisciplinary Management of Head and Neck Cancer. Invited, Patna, Bihar, US.
      2. 2010. Escalation to De-escalation? The Emerging Role of Treatment for HPV Positive Disease. Invited, Patna, Bihar, US.
      3. 2009. Post Residency Fellowships. Invited. Chicago, IL, US.
      4. 2007. Hepatocellular Carcinoma. Invited. Galveston, TX, US.
      5. 2007. The Treatment of Prostate and Breast Cancer. Invited. New York, NY, US.
      6. 2007. Imaging in the Treatment of Breast Cancer. Invited. New York, NY, US.
      7. 2006. Stereotactic Radiosurgery. Invited. Bronx, NY, US.
      8. 2005. Cervical Cancer. Invited. Bronx, NY, US.
      9. 2005. Pancreatic Cancer. Invited. Bronx, NY, US.
      10. 2004. Management of Rectal Carcinoma. Invited. Bronx, NY, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - 2031
      Title:FUEL-OPC: Diet Quality as a Catalyst for Oropharyngeal Cancer Survival
      Funding Source:National Institutes of Health
      Role:PI
      ID:1 R01 MD021574-01
      Title:Road to Wellness Program
      Funding Source:United 4 a Cure
      Role:Principal Investigator-MDACC
      Title:Dietary Correlates of IGF-1
      Funding Source:United 4 a Cure
      Role:Principal Investigator-MDACC

      Selected Publications

      Peer-Reviewed Articles

      1. Frank, SJ, Busse, PM, Lee, JJ, Rosenthal, D, Hernandez, M, Swanson, DM, Garden, AS, Gunn, GB, Patel, SH, Snider, JW, Ma, DJ, Molitoris, JK, Lee, N, Parvathaneni, U, McDonald, MW, Kalman, NS, Lin, A, Mohammed, N, Henson, CE, Hyde, C, Bajaj, GK, Katz, SR, Dagan, R, Morrison, WH, Reddy, JP, Fuller, C, Shah, SJ, Phan, J, Chronowski, G, Mayo, LL, Sturgis, EM, Ferrarotto, R, Zhu, XR, Zhang, X, Wang, L, Hutcheson, KA, El-Naggar, AK, Moreno, AC, Lee, A, Spiotto, MT, Gross, N, Lai, SY, Liao, JJ, Paly, JJ, Liao, Z, Foote, RL, Bates, JE, Chambers, MS, Chun, SG, Kaiser, A, Lester, SC, Lukens, JN, McGee, LA, Neben-Wittich, MA, Nguyen, Q, Routman, DM, Schlembach, PJ, Skinner, H, Soike, MH, Rwigema, JM, Wiederhold, LR, Blanchard, P, Choi, I, Koong, A, Langendijk, H, Mohan, R, Carlson, BJ, Mapps, A, Sarmiento, JG, Teferra, MY, Bosch, WR, Followill, DS, Taylor, PA, Fuentes, SY, Ning, M, Toumazis, I, Wogan, CF, De Gracia, B, Fink, K, Grippin, A, Ma, J, Pettersen, EA, Sareyeldin, RM, Cronin, C, Muise, S, Johnson, M, Pyfferoen, K, Tranby, BN, Leonard, J, Watkin, S, Eggleston, C, Barrow, B, Wolcott, J, Antonio, J, Brand, J, Cleverdon, A, Drake, M, Peters, E, Small, C, Clark, K, Holder, R. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA. The Lancet 407(10524):174-184, 2026. e-Pub 2026. PMID: 41391462.
      2. Karimzad, K, Shah, SJ, Kry, SF, Peeler, CR, Pollard-Larkin, JM, Koduri, A, Chacon Portillo, M, Chauhan, S, Amatullah, A, Miller, C, Strang, A, Song, J, Mir Zaman Shah, K, Lopez, D, Wagner, D, Tsai, J, Vachhani, S, Thakar, DR, Iliescu, C, Durand, J, Dougherty, AH, Kantharia, BK, Deswal, A. Safety of Contemporary Radiation Therapy in Patients With Cardiac Implantable Electronic Devices. Journal of the American Heart Association 14(17), 2025. e-Pub 2025. PMID: 40847479.
      3. Sahin, O, Kamel, S, Wahid, K, Dede, C, Taku, N, He, R, Naser, M, Sharafi, CS, Mäkitie, AA, Kann, BH, Kaski, K, Sahlsten, J, Jaskari, J, Amit, M, Chronowski, G, Diaz Jr, EM, Garden, AS, Goepfert, RP, Guenette, JP, Gunn, GB, Hirvonen, J, Hoebers, F, Hutcheson, KA, Guha-Thakurta, N, Johnson, JM, Kaya, D, Khanpara, SD, Nyman, K, Lai, SY, Lango, MN, Learned, KO, Lee, A, Lewis, CM, Maniakas, A, Moreno, AC, Myers, JN, Phan, J, Pytynia, KB, Rosenthal, D, Sandulache, VC, Schellingerhout, D, Shah, SJ, Sikora, AG, Mohamed, AS, Chen, MM, Fuller, C. International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography. Cancer 131(7), 2025. e-Pub 2025. PMID: 40159431.
      4. Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial. Int J Radiat Oncol Biol Phys 121(4):885-893, 2025. e-Pub 2025. PMID: 39486645.
      5. Mohamad, O, Kouzi, ZE, Kouzy, R, Choi, S, Mok, H, Hoffman, K, Nguyen, Q, Hassanzadeh, CJ, Tang, C, Park, RJ, Shah, SJ, McGuire, SE, Mayo, LL, Kim, Y, Prajapati, S, Vijayan, S, Kudchadker, RJ, Bruno, TL, Frank, SJ. Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer. Brachytherapy 24(2):1-9, 2025. e-Pub 2025. PMID: 40024668.
      6. Carriere, P, Alhalabi, O, Gao, J, Mohamad, O, Campbell, M, Shah, AY, Goswami, S, Bree, KK, Lee, B, Navai, N, Mok, H, Mayo, LL, Guo, CC, Nguyen, Q, McGuire, SE, Park, R, Shah, SJ, Hoffman, K, Frank, SJ, Tang, C, Choi, S, Kamat, A, Hassanzadeh, CJ. Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer. Clinical and Translational Radiation Oncology 49, 2024. e-Pub 2024. PMID: 39403573.
      7. Chung CV, Khan MS, Olanrewaju A, Pham M, Nguyen QT, Patel T, Das P, O'Reilly MS, Reed VK, Jhingran A, Simonds H, Ludmir EB, Hoffman KE, Naidoo K, Parkes J, Aggarwal A, Mayo LL, Shah SJ, Tang C, Beadle BM, Wetter J, Walker G, Hughes S, Mullassery V, Skett S, Thomas C, Zhang L, Nguyen S, Mumme RP, Douglas RJ, Baroudi H, Court LE. Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites. Radiother Oncol 202:110609, 2024. e-Pub 2024. PMID: 39486482.
      8. Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Koay, EJ. Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy. Oral Oncology 157, 2024. e-Pub 2024. PMID: 39024700.
      9. Sosa, A, Rooney, MK, Thames, HD, Sanders, JW, Swanson, DM, Choi, S, Nguyen, Q, Mok, H, Kuban, DA, Ron Zhu, X, Shah, SJ, Mayo, LL, Hoffman, K, Tang, C, McGuire, SE, Sahoo, N, Zhang, X, Lee, AK, Pugh, T, Mahmood, U, Davis, JW, Chapin, BF, Corn, P, Kudchadker, R, Ausat, N, Frank, SJ. Proton therapy toxicity outcomes for localized prostate cancer. Clinical and Translational Radiation Oncology 48, 2024. e-Pub 2024. PMID: 39188999.
      10. Weng, JK, Mesko, S, Chronowski, G, Lee, PP, Choi, S, Das, P, Koong, A, French, KE, Aloia, TA, Ehlers, R, Elrod-Joplin, D, Kerr, A, Smith, R, Martinez, W, Bloom, ES, Shah, SJ, Ning, M, Liao, Z, Herman, JM, Moningi, S, Moreno, AC, Nguyen, Q. Optimizing Outpatient Radiation Oncology Consult Workflow by Using Time-Driven Activity-Based Costing. JCO Oncology Practice 20(5):732-738, 2024. e-Pub 2024. PMID: 38330252.
      11. Wang, L, Sanders, JW, Ward, JF, Lee, SR, Poenisch, F, Swanson, DM, Sahoo, N, Zhu, XR, Ma, J, Kudchadker, RJ, Choi, S, Nguyen, Q, Mayo, LL, Shah, SJ, Frank, SJ. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy. Cancers 16(3), 2024. e-Pub 2024. PMID: 38339376.
      12. Garg, AK, Hernandez, M, Schlembach, PJ, Bowers, JR, McAleer, MF, Brown, P, Gopal, R, Wiederhold, LR, Swanson, T, Shah, SJ, Li, J, Ferguson, SD, Philip, NV, Degracia, L, Bloom, ES, Chun, SG. A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases. JNCI Cancer Spectrum 7(6), 2023. e-Pub 2023. PMID: 37944053.
      13. Sosa, A, Thames, HD, Sanders, JW, Choi, S, Nguyen, Q, Mok, H, Zhu, XR, Shah, SJ, Mayo, LL, Hoffman, K, Tang, C, Lee, AK, Pugh, T, Kudchadker, R, Frank, SJ. Proton therapy for the management of localized prostate cancer. Radiotherapy and Oncology 188, 2023. e-Pub 2023. PMID: 37597805.
      14. Contrera, KJ, Tam, S, Pytynia, KB, Diaz Jr, EM, Hessel, AC, Goepfert, RP, Lango, MN, Su, SY, Myers, JN, Weber, RS, Eguia, A, Pisters, PW, Adair, DK, Nair, AS, Rosenthal, D, Mayo, LL, Chronowski, G, Zafereo, M, Shah, SJ. ASO Visual Abstract. Annals of surgical oncology 30(4):2341-2342, 2023. e-Pub 2023. PMID: 36720835.
      15. Contrera, KJ, Tam, S, Pytynia, KB, Diaz Jr, EM, Hessel, AC, Goepfert, RP, Lango, MN, Su, SY, Myers, JN, Weber, RS, Eguia, A, Pisters, PW, Adair, DK, Nair, AS, Rosenthal, D, Mayo, LL, Chronowski, G, Zafereo, M, Shah, SJ. Impact of Cancer Care Regionalization on Patient Volume. Annals of surgical oncology 30(4):2331-2338, 2023. e-Pub 2023. PMID: 36581726.
      16. Ng, SP, Cardenas, CE, Bahig, H, Elgohari, B, Wang, J, Johnson, JM, Moreno, AC, Shah, SJ, Garden, AS, Phan, J, Gunn, GB, Frank, SJ, Ding, Y, Na, L, Yuan, Y, Urbauer, D, Mohamed, AS, Rosenthal, D, Morrison, WH, MacManus, M, Fuller, C. Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer. Current Oncology 29(9):6303-6313, 2022. e-Pub 2022. PMID: 36135064.
      17. Diao, K, Nguyen, TP, Moreno, AC, Reddy, JP, Garden, AS, Wang, C, Tung, S, Wang, C, Wang, XA, Rosenthal, D, Fuller, C, Gunn, GB, Frank, SJ, Morrison, WH, Shah, SJ, Lee, A, Spiotto, MT, Su, SY, Ferrarotto, R, Phan, J. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival. Head and Neck 43(11):3331-3344, 2021. e-Pub 2021. PMID: 34269492.
      18. Weng, JK, Lei, X, Schlembach, PJ, Bloom, ES, Shaitelman, SF, Arzu, I, Chronowski, G, Dvorak, T, Grade, E, Hoffman, K, Perkins, GH, Reed, VK, Shah, SJ, Stauder, MC, Strom, EA, Tereffe, W, Woodward, W, Hortobagyi, GN, Hunt, KK, Buchholz, TA, Smith, B. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. International Journal of Radiation Oncology Biology Physics 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
      19. Patel, RR, He, K, Barsoumian, H, Chang, JY, Tang, C, Verma, V, Comeaux, N, Chun, SG, Gandhi, S, Truong, M, Erasmus, JJ, Hong, DS, Lee, PP, Ning, M, Nguyen, Q, Heymach, JV, Altan, M, Blumenschein, GR, Fossella, FV, Sezen, D, Chen, D, Carter, B, Davies, MA, Glitza, IC, Diab, A, Ferrarotto, R, Cabanillas, ME, Yuan, Y, Shah, SJ, Parra Cuentas, ER, Sun, B, Cortez, MA, Welsh, J. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy. Radiotherapy and Oncology 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
      20. Gunn, GB, Garden, AS, Ye, R, Ausat, N, Dahlstrom, KR, Morrison, WH, Fuller, C, Phan, J, Reddy, JP, Shah, SJ, Mayo, LL, Chun, SG, Chronowski, G, Moreno, AC, Myers, JN, Hanna, EY, Esmaeli, B, Gillison, M, Ferrarotto, R, Hutcheson, KA, Chambers, MS, Ginsberg, LE, El-Naggar, AK, Rosenthal, D, Zhu, XR, Frank, SJ. Proton therapy for head and neck cancer. International Journal of Particle Therapy 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
      21. Smith, GL, Fu, S, Ning, M, Nguyen, DK, Busse, PM, Foote, RL, Garden, AS, Gunn, GB, Fuller, C, Morrison, WH, Chronowski, G, Shah, SJ, Mayo, LL, Phan, J, Reddy, JP, Snider, JW, Patel, SH, Katz, SR, Lin, A, Mohammed, N, Dagan, R, Lee, N, Rosenthal, D, Frank, SJ. Work outcomes after intensity- modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for oropharyngeal cancer. International Journal of Particle Therapy 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
      22. Hanania, A, Zhang, X, Gunn, GB, Rosenthal, D, Garden, AS, Fuller, C, Phan, J, Reddy, JP, Moreno, AC, Chronowski, G, Shah, SJ, Ausat, N, Hanna, EY, Ferrarotto, R, Frank, SJ. Proton therapy for major salivary gland cancer. International Journal of Particle Therapy 8(1):261-272, 2021. e-Pub 2021. PMID: 34285952.
      23. Christopherson, KM, Moreno, AC, Elgohari, B, Gross, N, Ferrarotto, R, Mohamed, AS, Gunn, GB, Goepfert, RP, Mott, FE, Shah, SJ, Fuller, C, Reddy, JP, Frank, SJ, Morrison, WH, Phan, J, Rosenthal, D, Garden, AS. Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation. Oral Oncology 113, 2021. e-Pub 2021. PMID: 33360375.
      24. Ng, SP, Wang, H, Pollard, C, Nguyen, TP, Bahig, H, Fuller, C, Gunn, GB, Garden, AS, Reddy, JP, Morrison, WH, Shah, SJ, Rosenthal, D, Frank, SJ, Guha-Thakurta, N, Ferrarotto, R, Hanna, EY, Su, SY, Phan, J. Patient Outcomes after Reirradiation of Small Skull Base Tumors using Stereotactic Body Radiotherapy, Intensity Modulated Radiotherapy, or Proton Therapy. Journal of Neurological Surgery, Part B: Skull Base 81(6):638-644, 2020. e-Pub 2020. PMID: 33381367.
      25. Grant, SR, Williamson, TD, Stieb, S, Shah, SJ, Fuller, C, Rosenthal, D, Frank, SJ, Garden, AS, Morrison, WH, Phan, J, Moreno, AC, Reddy, JP, Cardoso, R, Liu, A, Wu, R, Gunn, GB. A Dosimetric Comparison of Oral Cavity Sparing in the Unilateral Treatment of Early Stage Tonsil Cancer. Advances in Radiation Oncology 5(6):1359-1363, 2020. e-Pub 2020. PMID: 33305099.
      26. Bagley, AF, Garden, AS, Reddy, JP, Moreno, AC, Frank, SJ, Rosenthal, D, Morrison, WH, Gunn, GB, Fuller, C, Shah, SJ, Ferrarotto, R, Sturgis, EM, Gross, N, Phan, J. Highly conformal reirradiation in patients with prior oropharyngeal radiation. Head and Neck 42(11):3326-3335, 2020. e-Pub 2020. PMID: 32776401.
      27. Noticewala, SS, Koong, A, Bloom, ES, Choi, S, Chronowski, G, Ghafar, RA, Guadagnolo, BA, Gunn, GB, Klopp, AH, Lee, PP, Li, J, Liao, Z, Ludmir, EB, McAleer, MF, Nguyen, Q, Ning, M, Robinson, IJ, Rosenthal, D, Shah, SJ, Woodward, W, Zaebst, DJ, Dabaja, BS, Das, P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic. Advances in Radiation Oncology 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
      28. Ning, M, Dean, MK, Taylor, KA, Arzu, I, Fleming, N, Mutyala, N, Suresh, P, Lewis, MA, Tu, J, Hassid, VJ, Joe, T, Byler, C, Bloom, ES, Shah, SJ. Evaluation and Improvement of Bottlenecking in a Multidisciplinary Oncology Clinic. Cureus 11(5):e4583, 2019. e-Pub 2019. PMID: 31309008.
      29. Moreno, AC, Wilke, C, Wang, H, Tung, S, Pollard, C, Garden, AS, Morrison, WH, Rosenthal, D, Fuller, C, Gunn, GB, Reddy, JP, Shah, SJ, Frank, SJ, Takiar, V, Phan, J. Optimizing laryngeal sparing with intensity modulated radiotherapy or volumetric modulated arc therapy for unilateral tonsil cancer. Physics and Imaging in Radiation Oncology 10:29-34, 2019. e-Pub 2019. PMID: 33458265.
      30. Bloom, BC, Augustyn, A, Pezzi, T, Menon, H, Mayo, LL, Shah, SJ, Schwartz, DL, Chmura, SJ, Johnson, FM, Welsh, J, Chun, SG. Rescue of immunotherapy-refractory metastatic Merkel cell carcinoma with conventionally fractionated radiotherapy and concurrent pembrolizumab. Frontiers in Oncology 9(APR), 2019. e-Pub 2019. PMID: 31024834.
      31. Shaitelman, SF, Lei, X, Thompson, A, Schlembach, PJ, Bloom, ES, Arzu, I, Buchholz, DJ, Chronowski, G, Dvorak, T, Grade, E, Hoffman, K, Perkins, GH, Reed, VK, Shah, SJ, Stauder, MC, Strom, EA, Tereffe, W, Woodward, W, Amaya, D, Shen, Y, Hortobagyi, GN, Hunt, KK, Buchholz, TA, Smith, B. Three-year outcomes with hypofractionated versus conventionally fractionated whole-breast irradiation. Journal of Clinical Oncology 36(35):3495-3503, 2018. e-Pub 2018. PMID: 30379626.
      32. Shah, SJ, Holzwanger, E, Khwaja, R, Fang, D, Figueroa-Bodine, J, Iannuzzi, C, Shi, C. A Single-Site Retrospective, Nonrandomized Study of Accelerated Partial Breast Irradiation Brachytherapy for Early-Stage Breast Cancer Treatment to Evaluate Local Tumor Control, Cosmetic Outcome, and Toxicities. Technology in Cancer Research and Treatment 15(5):645-650, 2016. e-Pub 2016. PMID: 26206768.
      33. Edson, MA, Garden, AS, Takiar, V, Glisson, BS, Fuller, C, Gunn, GB, Beadle, BM, Morrison, WH, Frank, SJ, Shah, SJ, Tao, R, William Jr, WN, Weber, RS, Rosenthal, D, Phan, J. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head and Neck 38:E2091-E2099, 2016. e-Pub 2016. PMID: 26920665.
      34. Shaitelman, SF, Schlembach, PJ, Arzu, I, Ballo, MT, Bloom, ES, Buchholz, DJ, Chronowski, G, Dvorak, T, Grade, E, Hoffman, K, Kelly, P, Ludwig, MS, Perkins, GH, Reed, VK, Shah, SJ, Stauder, MC, Strom, EA, Tereffe, W, Woodward, W, Ensor, J, Baumann, DP, Thompson, A, Amaya, D, Davis, T, Guerra, W, Hamblin, L, Hortobagyi, GN, Hunt, KK, Buchholz, TA, Smith, B. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation. JAMA Oncology 1(7):931-941, 2015. e-Pub 2015. PMID: 26247543.
      35. Schwartz, DL, Garden, AS, Shah, SJ, Chronowski, G, Sejpal, SV, Rosenthal, D, Chen, Y, Zhang, Y, Zhang, L, Wong, P, Garcia, JA, Ang, K, Dong, L. Adaptive radiotherapy for head and neck cancer - Dosimetric results from a prospective clinical trial. Radiotherapy and Oncology 106(1):80-84, 2013. e-Pub 2013. PMID: 23369744.
      36. Chronowski, G, Garden, AS, Morrison, WH, Frank, SJ, Schwartz, DL, Shah, SJ, Beadle, BM, Gunn, GB, Kupferman, ME, Ang, K, Rosenthal, D. Unilateral radiotherapy for the treatment of tonsil cancer. International Journal of Radiation Oncology Biology Physics 83(1):204-209, 2012. e-Pub 2012. PMID: 22019242.
      37. Nelson, CL, Gifford, KA, Kirsner, S, Shah, SJ, Bloom, ES, Mason, BE, Arzu, I. SU‐E‐J‐144. Medical physics 38(6):3476, 2011. e-Pub 2011.
      38. Yaparpalvi, R, Guha, C, Kahan, N, Minsky, L, Danish, A, Shah, SJ, Engler, M, Kalnicki, S. Comparison of Intra‐Operative Computer Optimized and Nomogram‐Based Total Implant Activities in Prostate I‐125 Seed Implants. Medical physics 32(6):1954-1955, 2005. e-Pub 2005.
      39. Menthena, A, Deb, N, Oertel, M, Grozdanov, PN, Sandhu, J, Shah, SJ, Guha, C, Shafritz, DA, Dabeva, MD. Bone marrow progenitors are not the source of expanding oval cells in injured liver. Stem Cells 22(6):1049-1061, 2004. e-Pub 2004. PMID: 15536195.
      40. Iyengar, P, Combs, TP, Shah, SJ, Gouon-Evans, V, Pollard, JW, Albanese, C, Flanagan, L, Tenniswood, MP, Guha, C, Lisanti, MP, Pestell, RG, Scherer, PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22(41):6408-6423, 2003. e-Pub 2003. PMID: 14508521.

      Review Articles

      1. Robinson, DJ, Barsoumian, H, Nalin, AP, Verma, V, Niedzielski, JS, Puebla-Osorio, N, Hu, Y, Kang, M, Shah, SJ, Phan, J, Welsh, J. Real-World Guide for Delivering Immunotherapy With Radiation Therapy. Practical radiation oncology 16(3):222-233, 2026. e-Pub 2026. PMID: 41061930.
      2. Taku, N, Wang, L, Garden, AS, Rosenthal, D, Gunn, GB, Morrison, WH, Fuller, C, Phan, J, Reddy, JP, Moreno, AC, Spiotto, MT, Chronowski, G, Shah, SJ, Mayo, LL, Gross, N, Ferrarotto, R, Zhu, XR, Zhang, X, Frank, SJ. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck. Current treatment options in oncology 22(6), 2021. e-Pub 2021. PMID: 34086150.
      3. Guha, C, Shah, SJ, Ghosh, SS, Lee, SW, Roy-Chowdhury, N, Roy-Chowdhury, J. Molecular therapies for viral hepatitis. BioDrugs 17(2):81-91, 2003. e-Pub 2003. PMID: 12641487.

      Other Articles

      1. Contrera, KJ, Tam, S, Shah, SJ, Zafereo, M ASO Author Reflections. Annals of surgical oncology 30(4):2339-2340, 2023. PMID: 36645539.
      2. Shah, SJ, Reed, VK, Arzu, I Nurse navigators in early cancer care. Breast Diseases 26(1):31-32, 2015.
      3. Reed, VK, Shah, SJ, Schlembach, PJ PN0(i+) breast cancer. Breast Diseases 25(2):129-130, 2014.
      4. Shah, SJ, Arzu, I, Reed, VK Reducing time-to-treatment in underserved latinas with breast cancer. Breast Diseases 25(3):211-212, 2014.
      5. Shah, SJ Beneficial effects of a combined navigator/promotora approach for hispanic women diagnosed with breast abnormalities. Breast Diseases 24(2):134, 2013.

      Abstracts

      1. Moningi S, Kuban DA, Allen PK, Kanke J, Master P, Anscher M, Chapin B, Choi S, Chun SG, Chronowski GM, Delclos ME, Garg AK, Mayo LL, McGuire SE, Nguyen QN, Pettaway CA, Schlembach PJ, Shah SJ, Tang C, Hoffman KE. Prospective Cancer Control and Patient-reported Quality of Life after Post-prostatectomy Salvage Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology• Biology• Physics 102(3):E130 - E131, 2018. e-Pub 2018.
      2. Phan J, Garden AS, Gunn GB. Linear Accelerator–Based Stereotactic Ablative Radiation Therapy Reirradiation for Unresectable Recurrent Head and Neck Cancer, 2016. e-Pub 2016.

      Letters to the Editor

      1. Shaffer, R, Seegenschmiedt, MH, Koneru, B, Shah, SJ, Brown, P, Prabhu, AV, Thomas, TO. In Regard to Yu et al. Practical radiation oncology 16: 318-319, 2026.
      2. Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Lee, A, Koay, EJ. Response to recent comments on “Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy”. Oral Oncology 162, 2025.
      3. Ludmir, EB, Adlakha, EK, Chun, SG, Reed, VK, Arzu, I, Ahmad, N, Bloom, ES, Chronowski, G, Delclos, ME, Mayo, LL, Schlembach, PJ, Liao, Z, Koong, A, Herman, JM, Shah, SJ. Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncologica 58: 1135-1137, 2019.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 03, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top